Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 5 (2008), Issue 7 (July)

1. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
   Expert Rev Neurother, 8(7): 1037-48. [Abstract] [Full-text]
2. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.
   Psychopharmacology (Berl), 199(2): 223-30. [Abstract] [Full-text]
3. Beta-caryophyllene is a dietary cannabinoid.
   Proc Natl Acad Sci U S A, 105(26): 9099-104. [Abstract] [Full-text]
4. Children taking risks: the association with cocaine and other drug use by young adulthood.
   Addict Behav, 33(9): 1154-61. [Abstract] [Full-text]
5. Childhood predictors of adolescent marijuana use: early sensation-seeking, deviant peer affiliation, and social images.
   Addict Behav, 33(9): 1140-7. [Abstract] [Full-text]
6. Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men.
   Addict Behav, 33(9): 1131-9. [Abstract] [Full-text]
7. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
   Drug Alcohol Rev. [Abstract] [Full-text]
8. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
   Arch Gen Psychiatry, 65(7): 772-84. [Abstract] [Full-text]
9. Is driving under the influence of cannabis becoming a greater risk to driver safety than drink driving? Findings from a longitudinal study.
   Accid Anal Prev, 40(4): 1345-50. [Abstract] [Full-text]
10. Children's cognitive ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence.
    Dev Psychol, 44(4): 919-28. [Abstract] [Full-text]
11. Implementation of MET/CBT 5 for adolescents.
    J Behav Health Serv Res, 35(3): 304-14. [Abstract] [Full-text]
12. Earlier violent television exposure and later drug dependence.
    Am J Addict, 17(4): 271-7. [Abstract] [Full-text]
13. Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins.
    Drug Alcohol Depend, 97(1): 33-43. [Abstract] [Full-text]
14. Adherence to antiretrovirals among US women during and after pregnancy.
    J Acquir Immune Defic Syndr, 48(4): 408-17. [Abstract] [Full-text]
15. Attempts to stop or reduce marijuana use in non-treatment seekers.
    Drug Alcohol Depend, 97(1): 180-4. [Abstract] [Full-text]
16. Early childhood predictors of early substance use and substance use disorders: prospective study.
    Aust N Z J Psychiatry, 42(8): 720-31. [Abstract] [Full-text]
17. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Neurology, 71(3): 164-9. [Abstract] [Full-text]
18. Cannabinoids and hamster circadian activity rhythms.
    Brain Res, 1222: 141-8. [Abstract] [Full-text]
19. Developmental Validation of a Cannabis sativa STR Multiplex System for Forensic Analysis.
    J Forensic Sci. [Abstract] [Full-text]
20. Decision Making in Alcohol Dependence: Insensitivity to Future Consequences and Comorbid Disinhibitory Psychopathology.
    Alcohol Clin Exp Res. [Abstract] [Full-text]
21. Regional differences in alcohol consumption, alcohol addiction and drug use among Swedish adults.
    Scand J Public Health, 36(5): 493-503. [Abstract] [Full-text]
22. ENDOCANNABINOIDS AND THE NEUROCHEMISTRY OF GLUTTONY.
    J Neuroendocrinol. [Abstract] [Full-text]
23. Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.
    Trials, 9: 42. [Abstract] [Full-text]
24. The role of risk and protective factors in substance use across adolescence.
    J Adolesc Health, 43(2): 157-64. [Abstract] [Full-text]
25. Family meals and substance use: is there a long-term protective association?
    J Adolesc Health, 43(2): 151-6. [Abstract] [Full-text]
26. The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis.
    Schizophr Res, 103(1): 138-42. [Abstract] [Full-text]
27. Cannabis and schizophrenia.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
28. Promoting the implementation of an evidence-based intervention for adolescent marijuana abuse in community settings: testing the use of intensive quality assurance.
    J Clin Child Adolesc Psychol, 37(3): 682-9. [Abstract] [Full-text]
29. Cannabis smoke condensate I: the effect of different preparation methods on tetrahydrocannabinol levels.
    Inhal Toxicol, 20(9): 801-4. [Abstract] [Full-text]
30. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Eur J Pharmacol, 589(1): 117-21. [Abstract] [Full-text]
31. Cannabis smoking and acute coronary syndrome: two illustrative cases.
    Int J Cardiol, 128(2): e54-7. [Abstract] [Full-text]
32. Treatment compliance in adolescents after attempted suicide: a 2-year follow-up study.
    J Am Acad Child Adolesc Psychiatry, 47(8): 948-57. [Abstract] [Full-text]
33. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone.
    World J Biol Psychiatry. [Abstract] [Full-text]
34. The role of the CB1 receptor in the regulation of sleep.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(6): 1420-7. [Abstract] [Full-text]
35. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys.
    PLoS Med, 5(7): e141. [Abstract] [Full-text]
36. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives.
    Int J Ment Health Nurs, 17(4): 227-35. [Abstract] [Full-text]

© 2004-2013 Marijuana Research Today. All Rights Reserved.